 Anavex Life Sciences Corp NASDAQ:AVXL shares are trading higher by 25.7 at 19.49 after the company highlighted ANAVEX 2-73 and ANAVEX3-71 for Alzheimers were featured in the journal of Expert Opinion on Therapeutic Targets. Read more here... Anavex Life Sciences is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. 